For Nuplazid to add an indication in Alzheimer's psychosis, there is no way around conducting another study, an FDA panel member said. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
